Mutational Landscape of HER2-low Breast Carcinoma

被引：0
|
作者：
Lukose, Georgi [1 ]
Munoz-Zuluaga, Carlos [1 ]
Munoz-Arcos, Laura [2 ]
Michaud, Olivier [2 ]
Cristofanilli, Massimo [1 ]
Hoda, Syed [3 ]
Solomon, James [1 ]
机构：
[1] New York Presbyterian Weill Cornell Med, New York, NY USA
[2] New York Presbyterian Weill Cornell Med Ctr, New York, NY USA
[3] Weill Cornell Med, New York, NY USA
来源：
LABORATORY INVESTIGATION | 2023年 / 103卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
186
引用
收藏
页码：S176 / S177
页数：2
相关论文
共 50 条
  • [41] Landscape of HER2-low metastatic breast cancer (MBC): Results from the AGMT-MBC-Registry
    Gampenrieder, Simon Peter
    Rinnerthaler, Gabriel
    Petzer, Andreas
    Tinchon, Christoph
    Fuchs, David
    Balic, Marija
    Heibl, Sonja
    Rumpold, Holger
    Egle, Daniel
    Zabernigg, August Felix
    Singer, Christian Fridolin
    Andel, Johannes
    Hubalek, Michael
    Knauer, Michael
    Greil, Richard
    CANCER RESEARCH, 2020, 80 (04)
  • [42] The " lows " : Update on ER-low and HER2-low breast cancer
    Fusco, Nicola
    Viale, Giuseppe
    BREAST, 2024, 78
  • [43] HER2-LOW POSITIVE AND HER2-ZERO BREAST CANCERS ARE CLINICALLY DISTINCT
    不详
    CANCER DISCOVERY, 2021, 11 (09) : 2124 - 2124
  • [44] Current Updates in Management of HER2-Positive and HER2-Low Breast Cancer
    Arushi Thaper
    Jennifer Tran
    Azka Ali
    Current Breast Cancer Reports, 2023, 15 : 135 - 141
  • [45] Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer
    Paolo Tarantino
    Hersh Gupta
    Melissa E. Hughes
    Janet Files
    Sarah Strauss
    Gregory Kirkner
    Anne-Marie Feeney
    Yvonne Li
    Ana C. Garrido-Castro
    Romualdo Barroso-Sousa
    Brittany L. Bychkovsky
    Simona DiLascio
    Lynette Sholl
    Laura MacConaill
    Neal Lindeman
    Bruce E. Johnson
    Matthew Meyerson
    Rinath Jeselsohn
    Xintao Qiu
    Rong Li
    Henry Long
    Eric P. Winer
    Deborah Dillon
    Giuseppe Curigliano
    Andrew D. Cherniack
    Sara M. Tolaney
    Nancy U. Lin
    Nature Communications, 14
  • [46] ERBB2-Low (Also Known as HER2-Low) Breast Cancer
    Idossa, Dame
    Borrero, Maria
    Blaes, Anne
    JAMA ONCOLOGY, 2023, 9 (04) : 576 - 576
  • [47] Current Updates in Management of HER2-Positive and HER2-Low Breast Cancer
    Thaper, Arushi
    Tran, Jennifer
    Ali, Azka
    CURRENT BREAST CANCER REPORTS, 2023, 15 (02) : 135 - 141
  • [48] HER2-Low Breast Cancer Can Be Visualized by HER2 PET Reply
    Seban, Romain-David
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (11) : 1841 - 1842
  • [49] Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer
    Tarantino, P.
    Gupta, H.
    Hughes, M. E.
    Files, J.
    Strauss, S.
    Kirkner, G.
    Feeney, A. -M.
    Li, Y.
    Garrido-Castro, A. C.
    Barroso-Sousa, R.
    Bychkovsky, B. L.
    Dilascio, S.
    Sholl, L.
    Macconaill, L.
    Lindeman, N.
    Johnson, B. E.
    Meyerson, M.
    Jeselsohn, R.
    Qiu, X.
    Li, R.
    Long, H.
    Winer, E. P.
    Dillon, D.
    Curigliano, G.
    Cherniack, A. D.
    Tolaney, S. M.
    Lin, N. U.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [50] Defining the patient population with HER2-low breast cancer in Hawaii
    Beaman, Amanda Yachiyo
    Hayama, Sara
    Pagano, Ian
    Killeen, Jeffrey
    Fukui, Jami Aya
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345